X4 Pharmaceuticals nets $80.2mm through public offering

15:40 EDT 16 Apr 2019 | Elsevier Business Intelligence

X4 Pharmaceuticals Inc. (treatments for rare diseases and cancers) netted $80.2mm through a public offering. The company sold...

Original Article: X4 Pharmaceuticals nets $80.2mm through public offering


More From BioPortfolio on "X4 Pharmaceuticals nets $80.2mm through public offering"

Quick Search


Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...